Senate: Medtronic Shaped Articles Promoting InFuseA Senate report out Thursday concludes Minneapolis-based Medtronic helped write and edit medical journal articles attributed to outside physicians which downplayed the risks of Infuse, the company's best-selling bone graft, responsible for $800 million in annual sales.
Medtronic Says Bone Graft Investigation Is Over Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.
Thursday Night Football

Listen Live